GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

BGLC · Mar 31, 2024

BioNexus Gene Lab Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001477932-24-002941General Corporate
Operating cash generation58thOwn-history percentile · N=19
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1.45% · OPTIONAL · VALID

Revenue growth64thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.revenue

0.20% · CORE · VALID

Inventory pressure63thOwn-history percentile · N=19
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

45.21% · OPTIONAL · VALID

Gross margin53thOwn-history percentile · N=19
Evidence method

Level · gp.fundamentals.gross_margin

15.33% · CORE · VALID

Operating margin50thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.operating_margin

-3.32% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History29 statesSelf-history eligible
Sep 30, 20214/6 normalizedLevel 3Dec 31, 20214/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedAmended as filedDec 31, 20236/6 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/9 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition

What moved in the state?

Cash Generation Increased
Previous
-13.32%
Current
-1.45%
Delta
11.88%
Growth Increased
Previous
-10.60%
Current
0.20%
Delta
10.79%
Inventory Pressure Increased
Previous
11.64%
Current
45.21%
Delta
33.57%
Margin Increased
Previous
13.61%
Current
15.33%
Delta
1.72%
Profitability Increased
Previous
-26.54%
Current
-3.32%
Delta
23.23%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · BGLC Fundamental State →Transitioned To · BGLC CASH_GENERATION_INCREASED →Transitioned To · BGLC GROWTH_INCREASED →Transitioned To · BGLC INVENTORY_PRESSURE_INCREASED →Transitioned To · BGLC MARGIN_INCREASED →Transitioned To · BGLC PROFITABILITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.